Search Results

Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study.

• Authors : Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.; NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Methotrexate/Methotrexate/Methotrexate/*therapeutic use

• Source: RMD open [RMD Open] 2019 Feb 08; Vol. 5 (1), pp. e000840. Date of Electronic Publication: 2019 Feb 08 (Print Publication: 2019).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: eCollection Cited

Record details

Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial.

• Authors : McInnes IB; Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.; Ferraccioli G

Subjects: Body Mass Index*; Abatacept/Abatacept/Abatacept/*administration & dosage ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*administration & dosage

• Source: RMD open [RMD Open] 2019 May 30; Vol. 5 (1), pp. e000934. Date of Electronic Publication: 2019 May 30 (Print Publication: 2019).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: eCollection Cited

Record details

Efficacy and safety of abatacept to treat active birdshot uveitis: a prospective open label interventional proof-of-concept trial.

• Authors : Schauwvlieghe, P. P.; Van Calster, Joachim; Herbort Jr., Carl Peter

• Source: British Journal of Ophthalmology; Feb2024, Vol. 108 Issue 2, p244-252, 9p

Record details

Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.

• Authors : Baer, Alan N.; Gottenberg, Jacques-Eric; St Clair, E. William

Subjects: RESEARCH; CLINICAL trials; RESEARCH methodology

• Source: Annals of the Rheumatic Diseases; Mar2021, Vol. 80 Issue 3, p339-348, 10p

Record details

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48- week clinical and radiographic results of the investigatorinitiated randomised controlled NORD- STAR trial.

• Authors : Østergaard, Mikkel; van Vollenhoven, Ronald F.; Rudin, Anna

• Source: Annals of the Rheumatic Diseases; Oct2023, Vol. 82 Issue 10, p1286-1295, 144p

Record details

Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis.

• Authors : Chun Wu; Yanhua Hu; Schafer, Peter

• Source: RMD Open; Dec2022, Vol. 8 Issue 2, p1-12, 12p

Record details

Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.

• Authors : Ponsoye, Matthieu; Frantz, Camelia; Ruzehaji, Nadira

• Source: Annals of the Rheumatic Diseases; Dec2016, Vol. 75 Issue 12, p2142-2149, 8p, 6 Graphs

Record details

Case report: Rapid development of severe acute respiratory distress syndrome after abatacept treatment in a patient with rheumatoid arthritis.

• Authors : Gower, Jorge; Labarca, Gonzalo; Enos, Daniel

• Source: BMJ Case Reports; 4/6/2020, Vol. 13 Issue 4, p1-4, 4p, 1 Diagram, 1 Chart, 1 Graph

Record details

Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease.

• Authors : Ming-Han Chen; I-Cheng Lee; Ming-Huang Chen

• Source: Annals of the Rheumatic Diseases; Nov2021, Vol. 80 Issue 11, p1393-1399, 7p

Record details

Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies.

• Authors : Simon, Teresa A.; Lixian Dong; Suissa, Samy

• Source: Annals of the Rheumatic Diseases; Feb2024, Vol. 83 Issue 2, p177-183, 7p

Record details